CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences cash
Cash and short-term investments held at the end of each period.
CV Sciences's cash was $308.00K at Sep 30, 2026. For fiscal 2025 it was $278.00K, down 38.8% from the year before. Over ten years it grew -6.0% a year on average. The highest annual figure on record is $12.94M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $278.00K | -38.8% |
| FY2024 | Dec 31, 2024 | $454.00K | -65.5% |
| FY2023 | Dec 31, 2023 | $1.32M | +115.5% |
| FY2022 | Dec 31, 2022 | $611.00K | -55.6% |
| FY2021 | Dec 31, 2021 | $1.38M | -69.6% |
| FY2020 | Dec 31, 2020 | $4.53M | -52.9% |
| FY2019 | Dec 31, 2019 | $9.61M | -25.7% |
| FY2018 | Dec 31, 2018 | $12.94M | +363.3% |
| FY2017 | Dec 31, 2017 | $2.79M | +164.0% |
| FY2016 | Dec 31, 2016 | $1.06M | +104.0% |
| FY2015 | Dec 31, 2015 | $518.46K | -77.5% |
| FY2014 | Dec 31, 2014 | $2.30M | +2.6% |
| FY2013 | Dec 31, 2013 | $2.24M | +520473.1% |
| FY2012 | Dec 31, 2012 | $431 | -63.1% |
| FY2011 | Dec 31, 2011 | $1.17K | -96.2% |
| FY2010 | Dec 31, 2010 | $30.70K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $308.00K | -19.2% |
| Q2 FY2026 | Jun 30, 2026 | $266.00K | -70.0% |
| Q1 FY2026 | Mar 31, 2026 | $309.00K | -61.9% |
| Q4 FY2025 | Dec 31, 2025 | $278.00K | -38.8% |
| Q3 FY2025 | Sep 30, 2025 | $381.00K | -61.1% |
| Q2 FY2025 | Jun 30, 2025 | $886.00K | +85.7% |
| Q1 FY2025 | Mar 31, 2025 | $812.00K | +22.7% |
| Q4 FY2024 | Dec 31, 2024 | $454.00K | -65.5% |
| Q3 FY2024 | Sep 30, 2024 | $979.00K | -40.4% |
| Q2 FY2024 | Jun 30, 2024 | $477.00K | -71.8% |
| Q1 FY2024 | Mar 31, 2024 | $662.00K | -7.3% |
| Q4 FY2023 | Dec 31, 2023 | $1.32M | +115.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.64M | +44.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.69M | +51.7% |
| Q1 FY2023 | Mar 31, 2023 | $714.00K | -70.7% |
| Q4 FY2022 | Dec 31, 2022 | $611.00K | -55.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.14M | -31.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.11M | -54.7% |
| Q1 FY2022 | Mar 31, 2022 | $2.44M | -52.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.38M | -69.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.66M | -70.2% |
| Q2 FY2021 | Jun 30, 2021 | $2.46M | -67.5% |
| Q1 FY2021 | Mar 31, 2021 | $5.17M | -27.2% |
| Q4 FY2020 | Dec 31, 2020 | $4.53M | -52.9% |
| Q3 FY2020 | Sep 30, 2020 | $5.56M | -59.5% |
| Q2 FY2020 | Jun 30, 2020 | $7.58M | -50.3% |
| Q1 FY2020 | Mar 31, 2020 | $7.10M | -48.0% |
| Q4 FY2019 | Dec 31, 2019 | $9.61M | -25.7% |
| Q3 FY2019 | Sep 30, 2019 | $13.74M | +24.8% |
| Q2 FY2019 | Jun 30, 2019 | $15.24M | +110.7% |
| Q1 FY2019 | Mar 31, 2019 | $13.64M | +250.8% |
| Q4 FY2018 | Dec 31, 2018 | $12.94M | +363.3% |
| Q3 FY2018 | Sep 30, 2018 | $11.01M | +374.1% |
| Q2 FY2018 | Jun 30, 2018 | $7.23M | +281.1% |
| Q1 FY2018 | Mar 31, 2018 | $3.89M | +118.4% |
| Q4 FY2017 | Dec 31, 2017 | $2.79M | +164.0% |
| Q3 FY2017 | Sep 30, 2017 | $2.32M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.90M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.78M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.06M | – |
See a number that looks wrong?